Focal segmental glomerulosclerosis (FSGS)

By Mayo Clinic Staff
Feb. 01, 2025

Research

Mayo Clinic experts research and test new treatments for focal segmental glomerulosclerosis (FSGS) through the Mayo Nephrology Collaborative Group. As a Mayo Clinic patient, you may be able to participate in a clinical trial.

Publications

See a list of publications about focal segmental glomerulosclerosis by Mayo Clinic doctors on PubMed, a service of the National Library of Medicine.

  1. Focal segmental glomerulosclerosis (FSGS). National Kidney Foundation. https://www.kidney.org/atoz/content/focal. Accessed July 10, 2021.
  2. Reiser J. Epidemiology, classification, and pathogenesis of focal segmental glomerulosclerosis. https://www.uptodate.com/contents/search. Accessed July 10, 2021.
  3. Yu ASL, et al. Primary glomerular disease. In: Brenner and Rector's The Kidney. 11th ed. Elsevier; 2020.
  4. Rosenberg AZ, et al. Focal segmental glomerulosclerosis. Clinical Journal of the American Society of Nephrology. 2017; doi:10.2215/CJN.05960616.
  5. Medical review (expert opinion). Mayo Clinic. Aug. 8, 2021.
  6. What is a kidney biopsy? National Kidney Foundation. https://www.kidney.org/atoz/content/kidney-biopsy. Accessed July 10, 2021.
  7. AskMayoExpert. Glomerular disease. Mayo Clinic; 2020.
  8. Cattran DC, et al. Treatment of primary focal segmental glomerulosclerosis. https://www.uptodate.com/contents/search. Accessed July 10, 2021.
  9. Braswell-Pickering EA. Allscripts EPSi. Mayo Clinic. July 15, 2021.